[Physiological control mechanism of gastrointestinal motility].
Fujii
K
K
Research Facilities for Laboratory Animal Science, Hiroshima University School of Medicine.
D000109:Acetylcholine / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D015738:Famotidine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005755:Gastrins / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006632:Histamine / Q000502:physiology*; D006635:Histamine H2 Antagonists / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D015282:Octreotide / Q000031:analogs & derivatives / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D005755:Gastrins; D006635:Histamine H2 Antagonists; D007093:Imidazoles; C045210:3-Tyr-octreotide; D013779:Tetrodotoxin; C032368:midaglizole; D015738:Famotidine; D006632:Histamine; D000109:Acetylcholine; D015282:Octreotide; D009638:Norepinephrine